Skip to main content
. 2017 Feb 20;7:42289. doi: 10.1038/srep42289

Figure 2. Impact of KIFC1 knockdown on proliferation and migration of White (W) (HCC1143 and MDA-MB-231) and African American (AA) (HCC1806 and MDA-MB-468) triple-negative breast cancer (TNBC) cell lines.

Figure 2

(A) Western blots of KIFC1 from White and AA TNBC cell lines treated with control or KIFC1 siRNA. (B) Proliferation of White and AA TNBC cell lines following treatment with control or KIFC1 siRNA. (C) Micrographs from wound healing assays of White and AA TNBC cell lines treated with control or KIFC1 siRNA. (D) Percentage wound closure in White and AA TNBC cell lines following treatment with control or KIFC1 siRNA. *p < 0.01; ***p < 0.0001; ns = not significant.